Keyphrases
Omalizumab
100%
Systematic Literature Review
100%
Atopic Dermatitis
100%
Treatment Effect
28%
Embase
14%
High Affinity
14%
Clinical Benefit
14%
Complete Response
14%
Physician Assessment
14%
Fc Receptor
14%
Excellent Response
14%
Recommendations for Practice
14%
Beneficial Effects
14%
PubMed
14%
Recombinant Antibody
14%
Web of Science
14%
Referral Center
14%
Chronic Spontaneous Urticaria
14%
Antibody Targeting
14%
Best Response
14%
Clinical Practice
14%
Response to Treatment
14%
No Response
14%
Case-controlled
14%
Randomized Controlled Trial
14%
Starting Dose
14%
Immunology and Microbiology
Atopic Dermatitis
100%
Omalizumab
100%
Fc Receptor
14%
Allergic Asthma
14%
Medline
14%
Web of Science
14%
Chronic Urticaria
14%
Monoclonal Antibody
14%
Immunoglobulin E
14%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
100%
Omalizumab
100%
Randomized Controlled Trial
14%
Monoclonal Antibody
14%
Fc Receptor
14%
Allergic Asthma
14%
Chronic Urticaria
14%
Immunoglobulin E
14%
Deterioration
14%